Drugs / CTL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02496273 | Jan 2016 → Dec 2026 expected | gastric cancer | The First People's Hospital of Changzhou | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02496273 ↗ |
| Route | Intravenous | “The cells will be injected by IV into the patient.” NCT02496273 ↗ |